Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
Arthritis Research & Therapy|June 8, 2010
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritisFiona E McCann, Andrew C Palfreeman, Melanie Andrews, et al.Wellcome Open Research|March 7, 2020
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response studyJagdeep Nanchahal, Catherine Ball, Jennifer Swettenham, et al.Pain|March 31, 2010
Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint painKay E McNamee, Annika Burleigh, Luke L Gompels, et al.Annals of Neurology|December 23, 2011
Resolving postoperative neuroinflammation and cognitive declineNiccolò Terrando, Lars I Eriksson, Jae Kyu Ryu, et al.Biology Open|March 7, 2020
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell statesThomas B Layton, Lynn Williams, Huw Colin-York, et al.Arthritis and Rheumatism|May 28, 2010
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritisStefan K Drexler, Philip Kong, Julia Inglis, et al.Proceedings of the National Academy of Sciences of the United States of America|October 11, 2019
TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cellsWen-Yi Tseng, Yi-Shu Huang, Felix Clanchy, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2014
Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritisFiona E McCann, Dany P Perocheau, Gerhard Ruspi, et al.Nature Communications|January 12, 2022
C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and protects against atherosclerosisInhye Park, Michael E Goddard, Jennifer E Cole, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentJennifer E Cole, Nagore Astola, Adam P Cribbs, et al.Pageof 15